[引用][C] Acute Lymphoblastic Leukemia and Invasive Mold Infections: A Challenging Field. J. Fungi 2022, 8, 1127

C Stafylidis, P Diamantopoulos, E Athanasoula… - 2022 - europepmc.org
Acute lymphoblastic leukemia (ALL) patients comprise a highly immunocompromised group
due to factors associated either with the treatment or the disease itself. Invasive mold …

Acute lymphoblastic leukemia and invasive mold infections: A challenging field

C Stafylidis, P Diamantopoulos, E Athanasoula… - Journal of Fungi, 2022 - mdpi.com
Acute lymphoblastic leukemia (ALL) patients comprise a highly immunocompromised group
due to factors associated either with the treatment or the disease itself. Invasive mold …

Incidence and risk factors for breakthrough invasive mold infections in acute myeloid leukemia patients receiving remission induction chemotherapy

HP Patel, AJ Perissinotti, TS Patel… - Open Forum …, 2019 - academic.oup.com
Background Despite fungal prophylaxis, invasive mold infections (IMIs) are a significant
cause of morbidity and mortality in patients with acute myeloid leukemia (AML) receiving …

1153. Characterization of Invasive Mold Infections in Acute Leukemia and Hematopoietic Stem Cell Transplant Recipient Patients and Risk Factors for Mortality-a …

R Kubat, P Subramanian, Y Li… - Open Forum …, 2020 - academic.oup.com
Abstract Background Invasive mold infections (IMIs) remain a significant cause of morbidity
and mortality in patients with acute leukemia (AL) and those undergoing hematopoietic stem …

755. Predictors of Mortality in Invasive Mold Infections Among Patients with Hematologic Malignancies and Hematopoietic Stem Cell Transplant Recipients

A Gupta, N Ranganath, MA Mendoza… - Open Forum …, 2022 - academic.oup.com
Abstract Background Invasive Mold Infections (IMI) cause significant morbidity and mortality,
particularly in patients with hematologic malignancies (HM) and hematopoietic stem cell …

[引用][C] Burden of invasive mold disease in patients with acute myelogenous leukemia and in stem cell transplant recipients.

XY Yang, WT Chen - … , Immunology, and Infection= Wei Mian yu gan …, 2015 - europepmc.org
Burden of invasive mold disease in patients with acute myelogenous leukemia and in stem cell
transplant recipients. - Abstract - Europe PMC Sign in | Create an account https://orcid.org …

Isavuconazole as primary antifungal prophylaxis in patients with acute myeloid leukemia or myelodysplastic syndrome: an open-label, prospective, phase 2 study

P Bose, D McCue, S Wurster… - Clinical Infectious …, 2021 - academic.oup.com
Background Mold-active primary antifungal prophylaxis (PAP) is routinely recommended in
neutropenic patients with newly diagnosed acute myeloid leukemia (AML) or high-risk …

The impact of prior invasive mold infections in leukemia patients who undergo allo-SCT in the era of triazole-based secondary prophylaxis

SP Georgiadou, RE Lewis, L Best, HA Torres… - Bone marrow …, 2013 - nature.com
Invasive mold infections (IMIs) can complicate intensive myelosuppressive chemotherapy for
hematological malignancies, particularly acute leukemia. As allogeneic hematopoietic SCT …

Comparison of the occurrence of mold infection among patients receiving chemotherapy for acute leukemia versus patients undergoing stem cell transplantation

A Janssen, T van der Bruggen… - European journal of …, 2011 - Wiley Online Library
Objectives: Invasive mold infections (IMI) are an important cause of morbidity and mortality in
patients with hematological malignancies. Cumulative incidence numbers vary greatly …

[HTML][HTML] Antifungal Prophylaxis and Risk for Invasive Mold Infections in Children with Hematologic Malignancies

A Ikwuezunma, A Dutta, MI Castellanos, H Paek… - Blood, 2020 - Elsevier
Background: Invasive mold infections (IMI) are a leading cause of mortality in
immunocompromised hosts. Children diagnosed with hematologic malignancies experience …